BLINCYTO 38,5 mikrogramov prašek za koncentrat in raztopina za raztopino za infundiranje
Country: Slovenia
Language: Slovenian
Source: JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
blinatumomab
Available from:
Amgen Europe B.V.
ATC code:
L01XC19
INN (International Name):
blinatumomab
Pharmaceutical form:
prašek za koncentrat in raztopina za raztopino za infundiranje
Composition:
blinatumomab 38,5 µg / 1 viala
Administration route:
Intravenska uporaba
Units in package:
škatla z 1 vialo praška za koncentrat za raztopino za infuzijo in 1 vialo raztopine (stabilizatorja)
Prescription type:
H - Predpisovanje in izdaja zdravila je le na recept, zdravilo pa se uporablja samo v bolnišnicah.
Therapeutic group:
blinatumomab
Authorization status:
Zdravilo z dovoljenjem za promet
Authorization date:
2016-01-25
